Should I buy Aviva shares for the dividend in 2022 and 2023?

Aviva shares have soared in value. Yet at current prices the insurer’s dividend yields still smash the market average. Should I buy the stock today?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Aviva (LSE: AV) shares have exploded in value following the release of strong financial results last week.

Yet despite this stunning rise, dividend yields at the FTSE 100 insurer remain enormous. For 2022, the shares carry a large 6.7% dividend yield. And for 2023 it moves to 7.1%.

These figures sprint past the Footsie forward average of 3.7%. But, of course, yield is based on broker estimates and, in reality, a final dividend can fall well short of City targets.

So how realistic are Aviva’s dividend forecasts right now? And should I buy the company for my Stocks and Shares ISA anyway?

Dividend cover

Dividend cover is one of the first things to look at when assessing a stock’s dividend prospects. Ideally, I look for payouts to be covered more than 2 times by anticipated earnings. Any reading below 1.5 could also suggest that dividend estimates might be a tad optimistic.

So whats the story for Aviva? A total payout of 31.4p per share is forecast for 2022. A larger 33.1p reward is expected for next year too. But based on these projections, dividend cover sits at just 1.4 and 1.6 times respectively.

Balance sheet

However, it’s also critical to look at the health of a company’s balance sheet. And in this regard I’m not as concerned about Aviva’s payout prospects as I am for many other UK income stocks. In fact, the firm’s cash-rich balance sheet is allowing it to return capital to shareholders at an impressive level.

Last week, the insurer said it will hike the interim dividend 40% year-on-year, to 10.3p per share. This was thanks to a sharp uptick in its capital ratio in the first half. Aviva’s Solvency II ratio ballooned to 213% from 186% a year earlier.

On top of this, it announced plans to launch another share buyback programme when it releases full-year results. This follows the £4.75bn capital return it executed back in May.

Is Aviva a buy?

Aviva’s share price467.9p
Price movement in 2022-15%
Market cap£13bn
Forward price-to-earnings (P/E) ratio10.9 times
Forward dividend yield6.7%
Dividend cover1.4 times

I’m expecting Aviva to pay the bulging dividends that brokers predict for 2022 and 2023. But as a long-term investor, I’m looking for more than this. I buy UK shares according to what returns I can expect, say, a decade from now.

I must say that I’m pretty excited by Aviva’s outlook for the next 10 years.

Thanks to massive restructuring and a drastically reduced geographic footprint, the company’s an excellent cash generator. Not only could this enable it to continue showering investors with big dividends, it also gives the firm financial firepower to carry out earnings-boosting acquisitions. Just like the recent £385m purchase of financial advisors Succession Wealth.

I also like its robust position in financial products like pensions and equity release. Demand for these products is likely to soar as Britain’s population rapidly ages. Furthermore, the steps it’s taking to digitalise its operations also gives it an edge over the broader market and should prove exceptional cross-selling opportunities.

Sure, sales might slip in the near term as the global economy weakens. But all things considered, I think it’s a top dividend stock to buy today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »

Investing Articles

After gaining over 200% in 12 months, what’s next for Nvidia stock?

Oliver thinks Nvidia stock could be as enduring an investment as Amazon. Even given the valuation risks, he says he…

Read more »